Stock Taper 
EVERSEPT PARTNERS, LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Revolution Medicines, Inc. | RVMD | 6.94K | $1.3M |
 Intuitive Surgical, Inc. | ISRG | 7.24K | $2.88M |
 Repligen Corporation | RGEN | 14.4K | $1.96M |
 Bio-Techne Corporation | TECH | 19.31K | $1.36M |
 Eli Lilly and Company | LLY | 20.12K | $24.13M |
 Glaukos Corporation | GKOS | 29.34K | $4.1M |
 Humana Inc. | HUM | 31.17K | $12.38M |
 Agilon Health, Inc. | AGL | 37.79K | $4.05M |
 Ascendis Pharma A/S | ASND | 41.62K | $11.1M |
 Odyssey Therapeutics, Inc. | ODTX | 49.66K | $929.1K |
 UnitedHealth Group Incorporated | UNH | 51.15K | $21.26M |
 Chemed Corporation | CHE | 52.52K | $24.46M |
 Tarsus Pharmaceuticals, Inc. | TARS | 55.71K | $3.51M |
 Protagonist Therapeutics, Inc. | PTGX | 58.5K | $7.17M |
 AnaptysBio, Inc. | ANAB | 69.98K | $4.72M |
 National Health Investors, Inc. | NHI | 70.67K | $5.39M |
 Molina Healthcare, Inc. | MOH | 80.59K | $18.43M |
 Revvity, Inc. | RVTY | 83.62K | $9.3M |
 Welltower Inc. | WELL | 87.31K | $19.82M |
 Relmada Therapeutics, Inc. | RLMD | 93.19K | $644.89K |